Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by MrMugsyon Aug 18, 2021 3:57pm
74 Views
Post# 33724952

RE:RE:RE:RE:RE:RE:RE:RE:RE:Analyst's Reports

RE:RE:RE:RE:RE:RE:RE:RE:RE:Analyst's ReportsAbsolutely EbbFlow - I'm bullish on this one.
I'm getting what I expected.
Sure we'd all like it to happen faster - grow quicker - but that doesn't concern me much.
Slow accumulation here is the right play for me - it has always been the right play for me.

I'm a little preoccupied with ATE right now ... this is the first time I went red on that play ... focusing  further accumulation there right now.  Will be back here buying eventually.  My plan to move ATE money here seems to be on hold for now ... hahaha!  Better days ahead !

-----


EbbFlow88 wrote: There have been many new investors since march 2020 that have built positions recently. The stock has been trading between 5 and 5.60 for the last number of months. 

Personally I initiated a position in the mid 6's but have since gone in much bigger between 5.10 and 5.30. My ACB is now just under 5.40

There are a few new faces here that I'm sure have an even better cost basis than me.

2% gain isn't anything to brag about, but even those that are still in the red (I assume Mugsy considering how long he's been here) are still very bullish and comfortable with what we own.

A while back you said Goodman will buy it back privately under $4, now its $5.50. Even you are getting more bullish.


<< Previous
Bullboard Posts
Next >>